Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Gynecologic 1Genitourinary 1Gastrointestinal 1Dermatologic 1CNS 1Breast 1

Conditions

Glioblastoma 6Gliosarcoma 3Brain Neoplasms 3Sarcoma 2Melanoma 2Glioma 2Gastrointestinal Neoplasms 2Central Nervous System Neoplasms 2Breast Neoplasms 2Wilms Tumor 1Uterine Cervical Neoplasms 1Small Cell Lung Carcinoma 1Recurrence 1Pheochromocytoma 1Paraganglioma, Extra-Adrenal 1Paraganglioma 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Osteosarcoma 1Optic Nerve Glioma 1Neuroblastoma 1Neoplasms 1Hypertension 1Head and Neck Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1

Interventions

ziprasidone 1pazopanib 1lutetium Lu 177 dotatate 1gallium Ga 68 dotatate 1clevidipine 1Zolpidem 1Warfarin 1Vecuronium Bromide 1Vancomycin 1Tranexamic Acid 1Tobramycin 1Spironolactone 1Sevelamer 1Rocuronium 1Piperacillin, Tazobactam Drug Combination 1Pentobarbital 1Oxycodone 1Nifedipine 1Nafcillin 1Molindone 1Methylprednisolone 1Lurasidone Hydrochloride 1Labetalol 1Haloperidol 1Fosfomycin 1Clozapine 1Ciprofloxacin 1Cidofovir 1Cefepime 1Bosentan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hypertension × pazopanib × CNS × Clear all
NCT01392352 2020-02-13

HYPAZ

Cambridge University Hospitals NHS Foundation Trust

Phase 2 Terminated
31 enrolled
BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicSarcomaThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Gastrointestinal Neoplasms, Glioblastoma, Hypertension, Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms, Sarcoma, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡